Archives
ASA: Racial Differences Seen in Treatment of Common Poststroke Sequelae
Black patients significantly less likely than non-Hispanic Whites to receive treatment for arousal, spasticity, mood at 14 days
Many Anesthesiologists Do Not Accurately Report Anesthesia Start Time
68.74 percent of cases had anesthesia start time documented after in-room time, corresponding to $638,671.57 of lost revenue
Outcomes Superior With CABG Versus Multivessel PCI
CABG linked to lower hospital mortality, fewer hospital admissions at three years, less repeat PCI, improved three-year survival
Restrictive, Liberal Fluid Strategies Yield Similar Outcomes for Sepsis-Induced Hypotension
All-cause death before discharge home by day 90 occurred in 14.0 percent of the restrictive fluid group and 14.9 percent in the liberal fluid group
Nab-Paclitaxel Does Not Increase Overall Survival in Biliary Tract Cancer
No significant improvement seen in survival with gemcitabine and cisplatin for patients with locally advanced disease, gallbladder adenocarcinoma
ASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B-Cell Lymphoma
39 percent of patients had a complete response, with median time to complete response of 42 days
ASH: Iron Deficiency More Likely in Formula-Fed Preemies
More infants in formula-fed versus breastfed group developed iron deficiency, despite having higher mean total daily iron intake
SABCS: Most Young Women With Breast Cancer Report Impact on Sexual Health
Vast majority also report their health care provider does not address sexual health issues
SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
Findings seen among young women with early-stage, hormone receptor-positive breast cancer desiring pregnancy
SABCS: Updated Analysis Confirms Endocrine Therapy Effective With/Without Chemo
Findings seen among HR-positive, HER2-negative, node-negative early breast cancer patients with recurrence score of 11 to 25
